000			02030 a2200541 4500
005			20250515202651.0
264		0	_c20100528
008			201005s 0 0 eng d
022			_a1555-905X
024	7		_a10.2215/CJN.08111109 _2doi
040			_aNLM _beng _cNLM
100	1		_aRobinson, Emily S
245	0	0	_aRapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial growth factor receptor inhibitor. _h[electronic resource]
260			_bClinical journal of the American Society of Nephrology : CJASN _cMar 2010
300			_a477-83 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCarcinoma _xdrug therapy
650	0	4	_aChi-Square Distribution
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHypertension _xchemically induced
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aProtein Kinase Inhibitors _xadministration & dosage
650	0	4	_aProteinuria _xchemically induced
650	0	4	_aQuinazolines _xadministration & dosage
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aSeverity of Illness Index
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aMatulonis, Ursula A
700	1		_aIvy, Percy
700	1		_aBerlin, Suzanne T
700	1		_aTyburski, Karin
700	1		_aPenson, Richard T
700	1		_aHumphreys, Benjamin D
773	0		_tClinical journal of the American Society of Nephrology : CJASN _gvol. 5 _gno. 3 _gp. 477-83
856	4	0	_uhttps://doi.org/10.2215/CJN.08111109 _zAvailable from publisher's website
999			_c19435718 _d19435718